(S)-1-(tert-Butoxycarbonyl)-2-(2,4-dichlorobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

3-[4-(propan-2-yl)phenyl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

4-bromo-1-(methanesulfonylmethyl)-1H-pyrazole, 97.0%, 250mg

Pipette microlitre monocanal ROTILABO®, 20 à 200 µl, 1 pièce

1,4-Dichloropyrido[4,3-d]pyridazine, 95.0%, 250mg

2-(N-cyclopropylcarbamoyl)cyclohexanecarboxylic acid, 97%, 2g

Potassium cinnamate, 95.0%, 5g

Ethyl 2-Cyano-2-methylpropionate>98.0%(GC)5g

1-(3-Bromobenzyl)-1H-pyrazol-5-amine, 1g

3-Methoxybenzene-1,2-diamine, 95.0%, 100mg

4-Bromo-2-(2,2,2-trifluoroethoxy)pyridine, 95.0%, 100mg

Adénosine diphosphate, 100 mg

tert-Butyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)azepane-1-carboxylate, 98%, 250mg